Zilver PTX Post-market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan: 2-Year Results
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-086X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Zilver PTX Post-market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan: 2-Year Results ; day:8 ; month:11 ; year:2018 ; pages:1-7
CardioVascular and interventional radiology ; (8.11.2018), 1-7
- Creator
-
Kichikawa, Kimihiko
Ichihashi, Shigeo
Yokoi, Hiroyoshi
Ohki, Takao
Nakamura, Masato
Komori, Kimihiro
Nanto, Shinsuke
O’Leary, Erin E.
Lottes, Aaron E.
Snyder, Scott A.
Dake, Michael D.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00270-018-2110-1
- URN
-
urn:nbn:de:101:1-2018122702203947174624
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kichikawa, Kimihiko
- Ichihashi, Shigeo
- Yokoi, Hiroyoshi
- Ohki, Takao
- Nakamura, Masato
- Komori, Kimihiro
- Nanto, Shinsuke
- O’Leary, Erin E.
- Lottes, Aaron E.
- Snyder, Scott A.
- Dake, Michael D.
- SpringerLink (Online service)
Other Objects (12)
A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
One-Year Outcomes of the Paclitaxel-Eluting Stent for TASC C and D Femoropopliteal Lesions in Real World
Bare metal stent versus paclitaxel eluting stent for intermediate length femoropopliteal arterial lesions (BATTLE trial): study protocol for a randomized controlled trial
Twelve-month results from the MAJESTIC trial of the Eluvia paclitaxel-eluting stent for treatment of obstructive femoropopliteal disease
Two-Year Follow-up of Sirolimus-Eluting Stents versus Paclitaxel-Eluting Stents in Acute Myocardial Infarction
Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the zilver PTX randomized trial
Drug-Eluting Coronary Stents: Hypersensitivity Reactions to Paclitaxel - A Case Report
Drug-coated balloon versus drug-eluting stent for femoropopliteal total occlusions: intraluminal versus subintimal approaches
Clinical Outcome of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation for the Treatment of Coronary Drug-Eluting Stent In-Stent Chronic Total Occlusion
Treatment of Femoropopliteal Arterial Disease in Critical Limb Ischemia with Drug Eluting Stents: A Real World Experience
Untersuchungen zur Anwendbarkeit von Polyelektrolytmultischichten für drug eluting stents zur lokalen Freisetzung von Paclitaxel
Mortality risk of femoropopliteal paclitaxel-coated devices remains inconclusive
A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
One-Year Outcomes of the Paclitaxel-Eluting Stent for TASC C and D Femoropopliteal Lesions in Real World
Bare metal stent versus paclitaxel eluting stent for intermediate length femoropopliteal arterial lesions (BATTLE trial): study protocol for a randomized controlled trial
Twelve-month results from the MAJESTIC trial of the Eluvia paclitaxel-eluting stent for treatment of obstructive femoropopliteal disease
Two-Year Follow-up of Sirolimus-Eluting Stents versus Paclitaxel-Eluting Stents in Acute Myocardial Infarction
Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the zilver PTX randomized trial
Drug-Eluting Coronary Stents: Hypersensitivity Reactions to Paclitaxel - A Case Report
Drug-coated balloon versus drug-eluting stent for femoropopliteal total occlusions: intraluminal versus subintimal approaches
Clinical Outcome of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation for the Treatment of Coronary Drug-Eluting Stent In-Stent Chronic Total Occlusion
Treatment of Femoropopliteal Arterial Disease in Critical Limb Ischemia with Drug Eluting Stents: A Real World Experience
Untersuchungen zur Anwendbarkeit von Polyelektrolytmultischichten für drug eluting stents zur lokalen Freisetzung von Paclitaxel
Mortality risk of femoropopliteal paclitaxel-coated devices remains inconclusive
A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
One-Year Outcomes of the Paclitaxel-Eluting Stent for TASC C and D Femoropopliteal Lesions in Real World
Bare metal stent versus paclitaxel eluting stent for intermediate length femoropopliteal arterial lesions (BATTLE trial): study protocol for a randomized controlled trial
Twelve-month results from the MAJESTIC trial of the Eluvia paclitaxel-eluting stent for treatment of obstructive femoropopliteal disease
Two-Year Follow-up of Sirolimus-Eluting Stents versus Paclitaxel-Eluting Stents in Acute Myocardial Infarction
Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the zilver PTX randomized trial
Drug-Eluting Coronary Stents: Hypersensitivity Reactions to Paclitaxel - A Case Report
Drug-coated balloon versus drug-eluting stent for femoropopliteal total occlusions: intraluminal versus subintimal approaches
Clinical Outcome of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation for the Treatment of Coronary Drug-Eluting Stent In-Stent Chronic Total Occlusion
Treatment of Femoropopliteal Arterial Disease in Critical Limb Ischemia with Drug Eluting Stents: A Real World Experience
Untersuchungen zur Anwendbarkeit von Polyelektrolytmultischichten für drug eluting stents zur lokalen Freisetzung von Paclitaxel